{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T16:46:21Z","timestamp":1790700381102,"version":"4.1.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,3,24]],"date-time":"2017-03-24T00:00:00Z","timestamp":1490313600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2017,3,24]],"date-time":"2017-03-24T00:00:00Z","timestamp":1490313600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000890","name":"National Multiple Sclerosis Society","doi-asserted-by":"publisher","award":["Collaborative Research Grant"],"award-info":[{"award-number":["Collaborative Research Grant"]}],"id":[{"id":"10.13039\/100000890","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["EY022936"],"award-info":[{"award-number":["EY022936"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["NS072141"],"award-info":[{"award-number":["NS072141"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["NS25304"],"award-info":[{"award-number":["NS25304"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"name":"the Guthy-Jackson Charitable Foundation"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["acta neuropathol commun"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s40478-017-0428-6","type":"journal-article","created":{"date-parts":[[2017,3,24]],"date-time":"2017-03-24T12:03:33Z","timestamp":1490357013000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":68,"title":["Myelin-specific multiple sclerosis antibodies cause complement-dependent oligodendrocyte loss and demyelination"],"prefix":"10.1186","volume":"5","author":[{"given":"Yiting","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine S.","family":"Given","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle E.","family":"Harlow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adeline M.","family":"Matschulat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy B.","family":"Macklin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey L.","family":"Bennett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory P.","family":"Owens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,3,24]]},"reference":[{"key":"428_CR1","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/2051-5960-2-48","volume":"2","author":"N Asavapanumas","year":"2014","unstructured":"Asavapanumas N, Verkman AS (2014) Neuromyelitis optica pathology in rats following intraperitoneal injection of NMO-IgG and intracerebral needle injury. Acta Neuropathol Commun 2:48. doi:\n                    10.1186\/2051-5960-2-48","journal-title":"Acta Neuropathol Commun"},{"key":"428_CR2","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1002\/ana.21802","volume":"66","author":"JL Bennett","year":"2009","unstructured":"Bennett JL, Lam C, Kalluri SR, Saikali P, Bautista K, Dupree C, Glogowska M, Case D, Antel JP, Owens GP et al (2009) Intrathecal pathogenic anti-aquaporin-4 antibodies in early neuromyelitis optica. Ann Neurol 66:617\u2013629","journal-title":"Ann Neurol"},{"key":"428_CR3","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1007\/s00401-015-1500-6","volume":"130","author":"K Blauth","year":"2015","unstructured":"Blauth K, Soltys J, Matschulat A, Reiter CR, Ritchie A, Baird NL, Bennett JL, Owens GP (2015) Antibodies produced by clonally expanded plasma cells in multiple sclerosis cerebrospinal fluid cause demyelination of spinal cord explants. Acta Neuropathol 130:765\u2013781","journal-title":"Acta Neuropathol"},{"key":"428_CR4","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1002\/ana.21837","volume":"66","author":"M Bradl","year":"2009","unstructured":"Bradl M, Misu T, Takahashi T, Watanabe M, Mader S, Reindl M, Adzemovic M, Bauer J, Berger T, Fujihara K et al (2009) Neuromyelitis optica: pathogenicity of patient immunoglobulin in vivo. Ann Neurol 66:630\u2013643","journal-title":"Ann Neurol"},{"key":"428_CR5","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.jneuroim.2011.08.002","volume":"238","author":"KM Brennan","year":"2011","unstructured":"Brennan KM, Galban-Horcajo F, Rinaldi S, O\u2019Leary CP, Goodyear CS, Kalna G, Arthur A, Elliot C, Barnett S, Linington C et al (2011) Lipid arrays identify myelin-derived lipids and lipid complexes as prominent targets for oligoclonal band antibodies in multiple sclerosis. J Neuroimmunol 238:87\u201395","journal-title":"J Neuroimmunol"},{"key":"428_CR6","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1126\/science.1190927","volume":"330","author":"B Emery","year":"2010","unstructured":"Emery B (2010) Regulation of oligodendrocyte differentiation and myelination. Science 330:779\u2013782","journal-title":"Science"},{"key":"428_CR7","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1038\/nrn1928","volume":"7","author":"RD Fields","year":"2006","unstructured":"Fields RD, Burnstock G (2006) Purinergic signalling in neuron-glia interactions. Nat Rev Neurosci 7:423\u2013436","journal-title":"Nat Rev Neurosci"},{"issue":"3","key":"428_CR8","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1056\/NEJMoa1601277","volume":"376","author":"SL Hauser","year":"2016","unstructured":"Hauser SL, Bar-Or A, Comi G, Giovannoni G, Hartung HP, Hemmer B, Lublin F, Montalban X, Rammohan KW, Selmaj K et al (2016) Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis. N Eng J Med 376(3):221\u2013234","journal-title":"N Eng J Med"},{"key":"428_CR9","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1073\/pnas.0708220105","volume":"105","author":"J Hauser","year":"2008","unstructured":"Hauser J, Sveshnikova N, Wallenius A, Baradaran S, Saarikettu J, Grundstrom T (2008) B-cell receptor activation inhibits AID expression through calmodulin inhibition of E-proteins. Proc Natl Acad Sci U S A 105:1267\u20131272","journal-title":"Proc Natl Acad Sci U S A"},{"key":"428_CR10","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1016\/S0140-6736(11)61649-8","volume":"378","author":"L Kappos","year":"2011","unstructured":"Kappos L, Li D, Calabresi PA, O\u2019Connor P, Bar-Or A, Barkhof F, Yin M, Leppert D, Glanzman R, Tinbergen J et al (2011) Ocrelizumab in relapsing-remitting multiple sclerosis: a phase 2, randomised, placebo-controlled, multicentre trial. Lancet 378:1779\u20131787","journal-title":"Lancet"},{"key":"428_CR11","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/j.expneurol.2016.03.009","volume":"283","author":"H Kiray","year":"2016","unstructured":"Kiray H, Lindsay SL, Hosseinzadeh S, Barnett SC (2016) The multifaceted role of astrocytes in regulating myelination. Exp Neurol 283:541\u2013549","journal-title":"Exp Neurol"},{"key":"428_CR12","first-page":"119","volume":"10","author":"J Li","year":"2016","unstructured":"Li J, Zhang L, Chu Y, Namaka M, Deng B, Kong J, Bi X (2016) Astrocytes in Oligodendrocyte Lineage Development and White Matter Pathology. Front Cell Neurosci 10:119","journal-title":"Front Cell Neurosci"},{"key":"428_CR13","doi-asserted-by":"publisher","unstructured":"Ligocki AJ, Rivas JR, Rounds WH, Guzman AA, Li M, Spadaro M, Lahey L, Chen D, Henson PM, Graves Det al (2015) A Distinct Class of Antibodies May Be an Indicator of Gray Matter Autoimmunity in Early and Established Relapsing Remitting Multiple Sclerosis Patients. ASN neuro 7: doi:\n                    10.1177\/1759091415609613","DOI":"10.1177\/1759091415609613"},{"key":"428_CR14","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1186\/s12974-016-0767-4","volume":"13","author":"Y Liu","year":"2016","unstructured":"Liu Y, Harlow DE, Given KS, Owens GP, Macklin WB, Bennett JL (2016) Variable sensitivity to complement-dependent cytotoxicity in murine models of neuromyelitis optica. J Neuroinflammation 13:301","journal-title":"J Neuroinflammation"},{"key":"428_CR15","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1002\/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q","volume":"47","author":"C Lucchinetti","year":"2000","unstructured":"Lucchinetti C, Bruck W, Parisi J, Scheithauer B, Rodriguez M, Lassmann H (2000) Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann Neurol 47:707\u2013717","journal-title":"Ann Neurol"},{"key":"428_CR16","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1111\/bpa.12099","volume":"24","author":"CF Lucchinetti","year":"2014","unstructured":"Lucchinetti CF, Guo Y, Popescu BF, Fujihara K, Itoyama Y, Misu T (2014) The pathology of an autoimmune astrocytopathy: lessons learned from neuromyelitis optica. Brain Pathol 24:83\u201397","journal-title":"Brain Pathol"},{"key":"428_CR17","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1177\/1352458516643396","volume":"22","author":"SK Ludwin","year":"2016","unstructured":"Ludwin SK, Rao V, Moore CS, Antel JP (2016) Astrocytes in multiple sclerosis. Mult Scler 22:1114\u20131124. doi:\n                    10.1177\/1352458516643396","journal-title":"Mult Scler"},{"key":"428_CR18","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1523\/JNEUROSCI.22-03-00876.2002","volume":"22","author":"BS Mallon","year":"2002","unstructured":"Mallon BS, Shick HE, Kidd GJ, Macklin WB (2002) Proteolipid promoter activity distinguishes two populations of NG2-positive cells throughout neonatal cortical development. J Neurosci 22:876\u2013885","journal-title":"J Neurosci"},{"key":"428_CR19","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1093\/brain\/awl370","volume":"130","author":"I Metz","year":"2007","unstructured":"Metz I, Lucchinetti CF, Openshaw H, Garcia-Merino A, Lassmann H, Freedman MS, Atkins HL, Azzarelli B, Kolar OJ, Bruck W (2007) Autologous haematopoietic stem cell transplantation fails to stop demyelination and neurodegeneration in multiple sclerosis. Brain 130:1254\u20131262","journal-title":"Brain"},{"key":"428_CR20","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1146\/annurev-immunol-032713-120240","volume":"32","author":"D Nayak","year":"2014","unstructured":"Nayak D, Roth TL, Mcgavern DB (2014) Microglia development and function. Annu Rev Immunol 32:367\u2013402","journal-title":"Annu Rev Immunol"},{"key":"428_CR21","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1179\/016164106X98099","volume":"28","author":"GP Owens","year":"2006","unstructured":"Owens GP, Bennett JL, Gilden DH, Burgoon MP (2006) The B cell response in multiple sclerosis. Neurol Res 28:236\u2013244","journal-title":"Neurol Res"},{"key":"428_CR22","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1002\/ana.21641","volume":"65","author":"GP Owens","year":"2009","unstructured":"Owens GP, Bennett JL, Lassmann H, O\u2019Connor KC, Ritchie AM, Shearer A, Lam C, Yu X, Birlea M, Dupree C et al (2009) Antibodies produced by clonally expanded plasma cells in multiple sclerosis cerebrospinal fluid. Ann Neurol 65:639\u2013649","journal-title":"Ann Neurol"},{"key":"428_CR23","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/nrneurol.2014.141","volume":"10","author":"MC Papadopoulos","year":"2014","unstructured":"Papadopoulos MC, Bennett JL, Verkman AS (2014) Treatment of neuromyelitis optica: state-of-the-art and emerging therapies. Nat Rev Neurol 10:493\u2013506","journal-title":"Nat Rev Neurol"},{"key":"428_CR24","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1146\/annurev-pathol-011811-132443","volume":"7","author":"BF Popescu","year":"2012","unstructured":"Popescu BF, Lucchinetti CF (2012) Pathology of demyelinating diseases. Annu Rev Pathol 7:185\u2013217","journal-title":"Annu Rev Pathol"},{"key":"428_CR25","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1002\/ana.23634","volume":"72","author":"JW Prineas","year":"2012","unstructured":"Prineas JW, Parratt JD (2012) Oligodendrocytes and the early multiple sclerosis lesion. Ann Neurol 72:18\u201331","journal-title":"Ann Neurol"},{"key":"428_CR26","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1111\/nyas.12841","volume":"1351","author":"M Prins","year":"2015","unstructured":"Prins M, Schul E, Geurts J, van der Valk P, Drukarch B, van Dam AM (2015) Pathological differences between white and grey matter multiple sclerosis lesions. Ann N Y Acad Sci 1351:99\u2013113","journal-title":"Ann N Y Acad Sci"},{"key":"428_CR27","doi-asserted-by":"publisher","first-page":"948976","DOI":"10.1155\/2013\/948976","volume":"2013","author":"KS Rawji","year":"2013","unstructured":"Rawji KS, Yong VW (2013) The benefits and detriments of macrophages\/microglia in models of multiple sclerosis. Clin Dev Immunol 2013:948976. doi:\n                    10.1155\/2013\/948976","journal-title":"Clin Dev Immunol"},{"key":"428_CR28","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1093\/brain\/awp309","volume":"133","author":"S Saadoun","year":"2010","unstructured":"Saadoun S, Waters P, Bell BA, Vincent A, Verkman AS, Papadopoulos MC (2010) Intra-cerebral injection of neuromyelitis optica immunoglobulin G and human complement produces neuromyelitis optica lesions in mice. Brain 133:349\u2013361","journal-title":"Brain"},{"key":"428_CR29","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1002\/glia.22272","volume":"60","author":"GK Sheridan","year":"2012","unstructured":"Sheridan GK, Dev KK (2012) S1P1 receptor subtype inhibits demyelination and regulates chemokine release in cerebellar slice cultures. Glia 60:382\u2013392","journal-title":"Glia"},{"key":"428_CR30","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1046\/j.1365-2990.2000.00217.x","volume":"26","author":"P van der Valk","year":"2000","unstructured":"van der Valk P, De Groot CJ (2000) Staging of multiple sclerosis (MS) lesions: pathology of the time frame of MS. Neuropathol Appl Neurobiol 26:2\u201310","journal-title":"Neuropathol Appl Neurobiol"},{"key":"428_CR31","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1126\/science.1206998","volume":"333","author":"H Wake","year":"2011","unstructured":"Wake H, Lee PR, Fields RD (2011) Control of local protein synthesis and initial events in myelination by action potentials. Science 333:1647\u20131651","journal-title":"Science"},{"key":"428_CR32","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1007\/s00401-013-1220-8","volume":"127","author":"C Wrzos","year":"2014","unstructured":"Wrzos C, Winkler A, Metz I, Kayser DM, Thal DR, Wegner C, Bruck W, Nessler S, Bennett JL, Stadelmann C (2014) Early loss of oligodendrocytes in human and experimental neuromyelitis optica lesions. Acta Neuropathol 127:523\u2013538","journal-title":"Acta Neuropathol"},{"key":"428_CR33","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1002\/ana.22551","volume":"70","author":"H Zhang","year":"2011","unstructured":"Zhang H, Bennett JL, Verkman AS (2011) Ex vivo spinal cord slice model of neuromyelitis optica reveals novel immunopathogenic mechanisms. Ann Neurol 70:943\u2013954","journal-title":"Ann Neurol"}],"container-title":["Acta Neuropathologica Communications"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-017-0428-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s40478-017-0428-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-017-0428-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,15]],"date-time":"2020-05-15T14:58:27Z","timestamp":1589554707000},"score":1,"resource":{"primary":{"URL":"https:\/\/actaneurocomms.biomedcentral.com\/articles\/10.1186\/s40478-017-0428-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,24]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["428"],"URL":"https:\/\/doi.org\/10.1186\/s40478-017-0428-6","relation":{},"ISSN":["2051-5960"],"issn-type":[{"value":"2051-5960","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,24]]},"assertion":[{"value":"16 March 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"25"}}